ARTICLE | Company News
Samaritan, Three Rivers Pharmaceuticals sales and marketing update
October 15, 2007 7:00 AM UTC
The companies extended a distribution deal for Three Rivers' Amphocil amphotericin B, a proton pump inhibitor, to include Ireland. LIV already had exclusive marketing rights to the invasive aspergill...